MNX1 and nasopharyngeal carcinoma: Interestingly, MNX1, a specific marker for pre- and postmitotic MNs [37] and described as being expressed in the developing spinal cord [38], was detected in NPC indicating that it was possible to generate NPC with a spinal fate after dual-SMAD inhibition.